| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8477611 | Molecular and Cellular Endocrinology | 2012 | 4 Pages |
Abstract
⺠Current therapies for advanced adrenocortical cancer are insufficient. ⺠The dual PI3K/mTOR inhibitor NVP-BEZ235 efficiently inhibits ACC cell proliferation. ⺠Concomitant inhibition of Erk may be required to potentiate the NVP-BEZ235 effect.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Mabrouka Doghman, Enzo Lalli,